Css LLC Viking Therapeutics, Inc. Call Options Transaction History

Css LLC

  • $999 Million
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$2.72 - $9.4 $88,400 - $305,500
32,500 New
32,500 $305,000
Q2 2020

Aug 14, 2020
BUY
$4.35 - $8.08 $4,350 - $8,080
1,000 Added 2.55%
40,200 $290,000
Q1 2020

May 15, 2020
BUY
$3.45 - $7.95 $109,365 - $252,015
31,700 Added 422.67%
39,200 $183,000
Q4 2019

Feb 14, 2020
BUY
$6.38 - $8.73 $47,850 - $65,475
7,500 New
7,500 $60,000

Others Institutions Holding VKTX

# of Institutions
474
Shares Held
66.2M
Call Options Held
5.72M
Put Options Held
3.39M
View Full List

About Viking Therapeutics, Inc.

VKTX Quotes by TradingView
  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.18B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email